Rahway, New Jersey
United States
16
2018-04-26
16
2020-04-14
These are the the leading inventors for applications assigned to Merck Sharp & Dohme:
Merck Sharp & Dohme based in Rahway, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for making phosphoramidate protected nucleoside compounds
#2 | 2017-03-23 ✅ Patent 10,000,454 granted on 2018-06-19Antidiabetic tricyclic compounds
#3 | 2016-02-04 ✅ Patent 9,518,055 granted on 2016-12-13Imidazopyridyl compounds as aldosterone synthase inhibitors
#4 | 2015-12-10 ✅ Patent 9,730,940 granted on 2017-08-15Purine inhibitors of human phosphatidylinositol 3-kinase delta
#5 | 2015-11-05 ✅ Patent 9,884,886 granted on 2018-02-06Disulfide masked prodrug compositions and methods
#6 | 2015-01-08 ✅ Patent 9,073,930 granted on 2015-07-07Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#7 | 2012-10-18 ✅ Patent 8,383,638 granted on 2013-02-26Aminobenzoquinazolinone M1 receptor positive allosteric modulators
#8 | 2012-08-02 ✅ Patent 8,349,830 granted on 2013-01-08Aryl aminopyridine PDE10 inhibitors
#9 | 2011-03-17 ✅ Patent 8,349,858 granted on 2013-01-08Polycyclic guanine derivatives and use thereof
#10 | 2010-07-15 ✅ Patent 8,278,337 granted on 2012-10-02Substituted pyridines that are JNK inhibitors
#11 | 2010-01-21 ✅ Patent 8,445,227 granted on 2013-05-21N-acetylglucosaminyltransferase III expression in lower eukaryotes
#12 | 2009-06-25 ✅ Patent 7,709,508 granted on 2010-05-04Estrogen receptor modulators
#13 | 2009-05-07 ✅ Patent 8,546,404 granted on 2013-10-01Compounds that are ERK inhibitors
#14 | 2009-03-12 ✅ Patent 8,080,543 granted on 2011-12-20Pyridine derivative potassium channel inhibitors
#15 | 2008-12-25 ✅ Patent 7,915,252 granted on 2011-03-29Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
#16 | 2007-02-01 ✅ Patent 7,723,352 granted on 2010-05-25Isoquinolinone potassium channel inhibitors
426206 ⎘